Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Capital Physio is one of the UK’s fastest growing providers of retail physiotherapy. Since inception in 2012, the group has opened 17 clinics as part of a highly scalable and growth driven business model.
days to go:
Expired
investment:
£6,210
Sauce of Nature are a fresh pesto brand free from additives and preservatives, being marketed as more than just a stir through pasta sauce but also to be drizzled over salad, as an accompaniment to meat, fish and vegetables or simply enjoyed on its own. They aim to be recognised nationally and internationally and are working on further products such as a vegan range.
days to go:
Expired
investment:
£36,140
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
Family Traveller aims to help and encourage families to have amazing experiences together. In 2013, Family Traveller launched their multi-platform media business to provide a trusted guide for families to help solve the problems and de-stress the process of family travel.
days to go:
Expired
investment:
£287,550
Signature Brew strives to craft beer that enhances the musical experience. Since 2011, their mission has been to create more collaborative beers with bands and musicians than any other brand globally. Through the success of their flagship beers, Studio Lager and Roadie All-Night IPA, they aim to spread their vision of uniting people through exceptional beer, music, and memorable experiences on a national and international scale.
Continuing their original objective of improving the beer scene at beloved venues and festivals, Signature Brew remains committed to this ethos. Their direct-to-consumer customer base is expanding across the UK, driven by partnerships with artists and venues within their community. Operating from their cutting-edge brewery in East London, which includes an iconic live music venue, they consistently produce award-winning beer while fervently supporting grassroots music.
days to go:
Expired
investment:
£872,392
Naturelly is low in calories and rich in vitamin C, designed to be fun, flavorsome and healthy for children. For every pouch sold a percentage is donated to the charity ''hope for children''. They have no added sugar or sweeteners and are suitable for vegans, vegetarians and for sufferers of all top 14 allergens.
days to go:
Expired
investment:
£50,184
